Variant report
Variant | esv3314685 |
---|---|
Chromosome Location | chr10:43182607-43186731 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:111)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
(count:3 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ZNF33B-1 | chr10:43186181-43186249 | NONHSAT139966 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000234864 | TF binding region |
ENSG00000272373 | chromatin interactions |
ENSG00000196693 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs191646974 | chr10:43182608-43182609 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs184114178 | chr10:43182653-43182654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs188854369 | chr10:43182683-43182684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs79618779 | chr10:43182755-43182756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs562418366 | chr10:43182769-43182770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs117744337 | chr10:43182787-43182788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs77404145 | chr10:43182811-43182812 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs12260958 | chr10:43182818-43182819 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs140257237 | chr10:43182828-43182829 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576381714 | chr10:43182830-43182831 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs115917007 | chr10:43182899-43182900 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs561829663 | chr10:43182974-43182975 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs114203313 | chr10:43183059-43183060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs185242630 | chr10:43183072-43183073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs35745281 | chr10:43183101-43183102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs116427932 | chr10:43183162-43183163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs190480470 | chr10:43183173-43183174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs74418287 | chr10:43183179-43183180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs557822330 | chr10:43183192-43183193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs570302466 | chr10:43183210-43183211 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs2473114 | chr10:43183225-43183226 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs182321207 | chr10:43183228-43183229 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs547046673 | chr10:43183244-43183245 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530065066 | chr10:43183264-43183265 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs370335047 | chr10:43183291-43183292 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs373878041 | chr10:43183296-43183297 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530530831 | chr10:43183321-43183322 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs572158147 | chr10:43183334-43183335 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs113418400 | chr10:43183338-43183339 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs370635605 | chr10:43183352-43183353 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs576291279 | chr10:43183379-43183380 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs372396204 | chr10:43183395-43183396 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs186039706 | chr10:43183399-43183400 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs376289143 | chr10:43183414-43183415 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs573710457 | chr10:43183424-43183425 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs188409231 | chr10:43183534-43183535 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs559597288 | chr10:43183581-43183582 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs115790125 | chr10:43183652-43183653 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs529242615 | chr10:43183653-43183654 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs551730253 | chr10:43183656-43183657 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs148015177 | chr10:43183719-43183720 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs531260066 | chr10:43183732-43183733 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs141694026 | chr10:43183742-43183743 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs181173987 | chr10:43183768-43183769 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs528900063 | chr10:43183773-43183774 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs371101630 | chr10:43183891-43183892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs547464911 | chr10:43183893-43183894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs565677845 | chr10:43183894-43183895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs539602566 | chr10:43183906-43183907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs185592771 | chr10:43183909-43183910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Lung cancer | 18438408 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Mental retardation | 21062444 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 22241247 | CNVD |
Intellectual disability | 21811512 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Obesity | 21956041 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Breast cancer | 21785460 | CNVD |
Autism | 20531469 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:43176200-43183000 | Weak transcription | K562 | blood |
2 | chr10:43182800-43184200 | Enhancers | Stomach Mucosa | stomach |
3 | chr10:43183000-43183200 | Enhancers | K562 | blood |
4 | chr10:43183200-43183800 | Weak transcription | K562 | blood |
5 | chr10:43183800-43184000 | Enhancers | K562 | blood |
6 | chr10:43183800-43184200 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
7 | chr10:43184000-43185200 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
8 | chr10:43184400-43185000 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
9 | chr10:43184400-43185600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr10:43184600-43185400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
11 | chr10:43184600-43185600 | Enhancers | Primary T helper memory cells from peripheral blood 1 | blood |
12 | chr10:43184600-43185600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
13 | chr10:43185600-43186200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
14 | chr10:43185600-43186600 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr10:43185800-43186200 | Enhancers | Pancreas | Pancrea |
16 | chr10:43186200-43190400 | Weak transcription | Pancreas | Pancrea |
17 | chr10:43186600-43187000 | Strong transcription | iPS DF 19.11 Cell Line | embryonic stem cell |